EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER
中国医学科学杂志(英文版)2006年0卷第4期 页码:214-218
Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER
Affiliations:
Author bio:
Funds:
DOI:
中图分类号:R445.2
纸质出版日期:2006
Accepted:
Scan QR Code
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER[J]. 中国医学科学杂志(英文版), 2006,0(4):214-218.
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER[J]. Chinese medical sciences journal, 2006, 0(4): 214-218.
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER[J]. 中国医学科学杂志(英文版), 2006,0(4):214-218.DOI:
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER[J]. Chinese medical sciences journal, 2006, 0(4): 214-218.DOI:
EVALUATION OF NEUROPROTECTIVE EFFECTS OF LONG-TERM LOW DOSE HORMONE REPLACEMENT THERAPY ON POSTMENOPAUSAL WO-MEN BRAIN HIPPOCAMPUS USING MAGNETIC RESONANCE SCANNER
摘要
Abstract
Objective To investigate the effects of long-term low dose hormone replacement therapy (HRT) on postmenopausal women in hormone level
cognition score
hippocampus volume
and magnetic resonance spectroscopy (MRS) parameters. Methods A total of 182 postmenopausal women aged 50-87 years were chosen at Peking Union Medical College Hospital and assigned to HRT group and control group. The volunteers of HRT group had taken low dose hormone [estradiol (E
2 ) 0.5-1.0 mg and progesterone 0.5-2.0 mg
once a day] for 4-33 years. The concentrations of E
2
progesterone
and testosterone were measured using enzyme-linked immunosorbent assay (ELISA). The gene types of apolipoprotein E (ApoE) were measured by polymerase chain reaction
and the subjects with susceptible genes (ApoE ε3/ε4) of Alzheimer’s disease (AD) were screened. Their hippocampus volumes and MRS parameters were obtained through magnetic resonance imaging (MRI)
and results in two groups were analyzed by statistical method. Results Compared with control group
the concentrations of E
2 at each age stage in HRT group were significantly higher (P
<
0.05) except the 80-89 years old subgroup; yet
there were no statistical differences in the concentrations of progesterone and testosterone between the two groups. There was no obvious difference in ApoE subtypes distribution between the two groups. The results of hippocampus MRI for the subjects with susceptible genes ApoE ε3/ε4 (HRT group 14 cases
control group 11 cases) showed that the ratio of bilateral hippocampus volume to whole brain volume in HRT group (0.406±0.028) was significantly higher than control group (0.369±0.031
P
<
0.05). The results of
1 H MRS for the subjects with susceptible genes ApoE ε3/ε4 (HRT group 12 cases
control group 11 cases) showed that the N-acetylaspartate/total creatine at the area of hippocampus in HRT group (1.54±0.08) were significantly higher than control group (1.45±0.13
P
<
0.05). Conclusions For postmenopausal women
long-term low dose HRT can maintain the physiological concentration of E
2 in plasma. Furthermore
the hippocampus MRI performed on those with ApoE ε3/ε4 genes shows that long-term low dose HRT can prevent hippocampus atrophy
which is beneficial to maintain the brain function and prevent AD.